188 related articles for article (PubMed ID: 38288038)
41. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
42. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
Qiu J; Yang T; Sun Y; Sun K; Xu Y; Xia Q
Oncol Res; 2024; 32(3):545-561. PubMed ID: 38361759
[TBL] [Abstract][Full Text] [Related]
43. Systematic analysis of expression profiles and prognostic significance for MMDS-related iron-sulfur proteins in renal clear cell carcinoma.
Yang L; Chen YX; Li YY; Liu XJ; Jiang YM; Mai J
Sci Rep; 2022 Nov; 12(1):19637. PubMed ID: 36385109
[TBL] [Abstract][Full Text] [Related]
44. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
[TBL] [Abstract][Full Text] [Related]
45. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
Front Immunol; 2022; 13():954440. PubMed ID: 36059510
[TBL] [Abstract][Full Text] [Related]
46. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
Front Immunol; 2022; 13():926461. PubMed ID: 36311770
[TBL] [Abstract][Full Text] [Related]
47. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis.
Zhao YW; Ma W; Jiang F; Xie Y; Tang L
Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474
[TBL] [Abstract][Full Text] [Related]
48. Effects and Prognostic Values of Circadian Genes CSNK1E/GNA11/KLF9/THRAP3 in Kidney Renal Clear Cell Carcinoma via a Comprehensive Analysis.
Li S; Wang X; Wang Q; Ding K; Chen X; Zhao Y; Gao Y; Wang Y
Bioengineering (Basel); 2022 Jul; 9(7):. PubMed ID: 35877357
[TBL] [Abstract][Full Text] [Related]
49. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
[TBL] [Abstract][Full Text] [Related]
50. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
[TBL] [Abstract][Full Text] [Related]
51. High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma.
Yang Y; Ye F; Xia T; Wang Q; Du J
BMC Cancer; 2022 Dec; 22(1):1355. PubMed ID: 36575439
[TBL] [Abstract][Full Text] [Related]
52. Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment.
Liao G; Wang P; Wang Y
Front Oncol; 2021; 11():720125. PubMed ID: 34336706
[TBL] [Abstract][Full Text] [Related]
53. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
[No Abstract] [Full Text] [Related]
54. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration.
Zheng D; Zhang Y; Xia Y; Cheng F
Front Oncol; 2022; 12():840410. PubMed ID: 35371994
[TBL] [Abstract][Full Text] [Related]
55. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
Front Oncol; 2022; 12():632042. PubMed ID: 35515103
[TBL] [Abstract][Full Text] [Related]
56. Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma.
Liu J; Li W; Wu L
Front Pharmacol; 2022; 13():950156. PubMed ID: 36046831
[TBL] [Abstract][Full Text] [Related]
57. Mining database and verification of PIK3CB as a marker predicting prognosis and immune infiltration in renal clear cell carcinoma.
Ye J; Zeng T
Medicine (Baltimore); 2022 Jun; 101(22):e29254. PubMed ID: 35665729
[TBL] [Abstract][Full Text] [Related]
58. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
[TBL] [Abstract][Full Text] [Related]
59. High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma.
Qiu J; Wang Z; Zhao L; Zhang P; Xu Y; Xia Q
Front Mol Biosci; 2023; 10():1201155. PubMed ID: 37529377
[No Abstract] [Full Text] [Related]
60. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
